BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Park JK, Lee EB, Shin K, Sung YK, Kim TH, Kwon SR, Lee MS, Hong SJ, Choi BY, Lee SS, Back HJ; Korean College of Rheumatology Task Force for COVID-19 Vaccine Guidance for Patients with Autoimmune Inflammatory Rheumatic Diseases. COVID-19 Vaccination in Patients with Autoimmune Inflammatory Rheumatic Diseases: Clinical Guidance of the Korean College of Rheumatology. J Korean Med Sci 2021;36:e95. [PMID: 33783147 DOI: 10.3346/jkms.2021.36.e95] [Cited by in Crossref: 9] [Cited by in F6Publishing: 6] [Article Influence: 9.0] [Reference Citation Analysis]
Number Citing Articles
1 Cherian S, Paul A, Ahmed S, Alias B, Manoj M, Santhosh AK, Varghese DR, Krishnan N, Shenoy P. Safety of the ChAdOx1 nCoV-19 and the BBV152 vaccines in 724 patients with rheumatic diseases: a post-vaccination cross-sectional survey. Rheumatol Int 2021;41:1441-5. [PMID: 34142203 DOI: 10.1007/s00296-021-04917-0] [Cited by in Crossref: 1] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
2 D'Amelio R, Asero R, Cassatella MA, Laganà B, Lunardi C, Migliorini P, Nisini R, Parronchi P, Quinti I, Racanelli V, Senna G, Vacca A, Maggi E. Anti-COVID-19 Vaccination in Patients with Autoimmune-Autoinflammatory Disorders and Primary/Secondary Immunodeficiencies: The Position of the Task Force on Behalf of the Italian Immunological Societies. Biomedicines 2021;9:1163. [PMID: 34572349 DOI: 10.3390/biomedicines9091163] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
3 Tzioufas AG, Bakasis AD, Goules AV, Bitzogli K, Cinoku II, Chatzis LG, Argyropoulou OD, Venetsanopoulou AI, Mavrommati M, Stergiou IE, Pezoulas V, Voulgari PV, Katsimpari C, Katechis S, Gazi S, Katsifis G, Sfontouris CI, Georgountzos AI, Liossis SN, Papagoras C, Fotiadis DI, Skopouli FN, Vlachoyiannopoulos PG, Moutsopoulos HM. A prospective multicenter study assessing humoral immunogenicity and safety of the mRNA SARS-CoV-2 vaccines in Greek patients with systemic autoimmune and autoinflammatory rheumatic diseases. J Autoimmun 2021;125:102743. [PMID: 34757289 DOI: 10.1016/j.jaut.2021.102743] [Reference Citation Analysis]
4 Yang J, Ko JH, Baek JY, Hong J, Ha S, Lee B, Huh K, Cho SY, Kang CI, Chung DR, Kim YJ, Kang ES, Peck KR. Effects of Short-Term Corticosteroid Use on Reactogenicity and Immunogenicity of the First Dose of ChAdOx1 nCoV-19 Vaccine. Front Immunol 2021;12:744206. [PMID: 34630425 DOI: 10.3389/fimmu.2021.744206] [Reference Citation Analysis]
5 Rossi A, Magri F, Michelini S, Caro G, Di Fraia M, Fortuna MC, Pellacani G, Carlesimo M. Recurrence of alopecia areata after covid-19 vaccination: A report of three cases in Italy. J Cosmet Dermatol 2021;20:3753-7. [PMID: 34741583 DOI: 10.1111/jocd.14581] [Reference Citation Analysis]
6 Hammam N, Tharwat S, Shereef RRE, Elsaman AM, Khalil NM, Fathi HM, Salem MN, El-Saadany HM, Samy N, El-Bahnasawy AS, Abdel-Fattah YH, Amer MA, ElShebini E, El-Shanawany AT, El-Hammady DH, Noor RA, ElKhalifa M, Ismail F, Fawzy RM, El-Najjar AR, Selim ZI, Abaza NM, Radwan AR, Elazeem MI, Mohsen WA, Moshrif AH, Mohamed EF, Aglan LI, Senara S, Ibrahim ME, Khalifa I, Owaidy RE, Fakharany NE, Mohammed RHA, Gheita TA; Egyptian College of Rheumatology (ECR) COVID-19 Study Group. Rheumatology university faculty opinion on coronavirus disease-19 (COVID-19) vaccines: the vaXurvey study from Egypt. Rheumatol Int 2021;41:1607-16. [PMID: 34244818 DOI: 10.1007/s00296-021-04941-0] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
7 Doskaliuk B, Yatsyshyn R, Klishch I, Zimba O. COVID-19 from a rheumatology perspective: bibliometric and altmetric analysis. Rheumatol Int 2021;41:2091-103. [PMID: 34596719 DOI: 10.1007/s00296-021-04987-0] [Reference Citation Analysis]
8 Luxi N, Giovanazzi A, Capuano A, Crisafulli S, Cutroneo PM, Fantini MP, Ferrajolo C, Moretti U, Poluzzi E, Raschi E, Ravaldi C, Reno C, Tuccori M, Vannacci A, Zanoni G, Trifirò G; Ilmiovaccino COVID19 collaborating group. COVID-19 Vaccination in Pregnancy, Paediatrics, Immunocompromised Patients, and Persons with History of Allergy or Prior SARS-CoV-2 Infection: Overview of Current Recommendations and Pre- and Post-Marketing Evidence for Vaccine Efficacy and Safety. Drug Saf 2021;44:1247-69. [PMID: 34739716 DOI: 10.1007/s40264-021-01131-6] [Reference Citation Analysis]
9 Wong PKK, Lahiri M, Lye DC, Johnson D, Charles PGP. A vaccination update for rheumatologists-SARS-CoV-2, influenza and herpes zoster. Int J Rheum Dis 2021;24:979-83. [PMID: 34350721 DOI: 10.1111/1756-185X.14179] [Reference Citation Analysis]
10 Seyahi E, Bakhdiyarli G, Oztas M, Kuskucu MA, Tok Y, Sut N, Ozcifci G, Ozcaglayan A, Balkan II, Saltoglu N, Tabak F, Hamuryudan V. Antibody response to inactivated COVID-19 vaccine (CoronaVac) in immune-mediated diseases: a controlled study among hospital workers and elderly. Rheumatol Int 2021;41:1429-40. [PMID: 34109466 DOI: 10.1007/s00296-021-04910-7] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 6.0] [Reference Citation Analysis]